166 related articles for article (PubMed ID: 2192105)
1. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
Sugano K; Okura H
Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
[No Abstract] [Full Text] [Related]
2. [Clinical significance of ST 272 Ag detected by the monoclonal antibody, NCC-ST-272].
Sekine T
Nihon Rinsho; 1990 Feb; 48 Suppl():1028-30. PubMed ID: 2192104
[No Abstract] [Full Text] [Related]
3. [Clinical significance of TAC-41 assay as a tumor marker].
Ariyoshi Y; Kuwabara M; Iwakoshi N; Kito K
Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
[No Abstract] [Full Text] [Related]
4. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
Shimano T; Morimoto H; Saito M; Mori T
Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
[No Abstract] [Full Text] [Related]
5. [Clinical significance of CA 195 assay as a tumor marker].
Ohkura H; Sakawaki T
Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
[No Abstract] [Full Text] [Related]
6. [Clinical significance of CA 50 assay as a tumor marker].
Hara K; Mitsuhashi F; Ohkura H
Nihon Rinsho; 1990 Feb; 48 Suppl():971-3. PubMed ID: 2192182
[No Abstract] [Full Text] [Related]
7. [Clinical significance of YH-206 assay analysis as a tumor marker].
Yachi A; Hinoda Y; Imai K; Endo T
Nihon Rinsho; 1990 Feb; 48 Suppl():1068-70. PubMed ID: 2192107
[No Abstract] [Full Text] [Related]
8. [Evaluation of KMO1 for the gastrointestinal disease].
Okumura S; Ohyanagi H; Saitoh Y
Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
[No Abstract] [Full Text] [Related]
9. The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker.
DelVillano BC; Zurawski VR
Lab Res Methods Biol Med; 1983; 8():269-82. PubMed ID: 6196588
[No Abstract] [Full Text] [Related]
10. [Clinical significance of CA 130 assay as a tumor marker].
Ariyoshi Y; Kuwabara M
Nihon Rinsho; 1990 Feb; 48 Suppl():985-8. PubMed ID: 2355640
[No Abstract] [Full Text] [Related]
11. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (1)].
Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1901-6. PubMed ID: 2439020
[TBL] [Abstract][Full Text] [Related]
12. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer].
Anzai K; Kurihara M; Izumi T
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836
[TBL] [Abstract][Full Text] [Related]
13. [NCC-ST-439].
Sugano K
Nihon Rinsho; 2005 Aug; 63 Suppl 8():681-3. PubMed ID: 16149610
[No Abstract] [Full Text] [Related]
14. [Clinical significance of DU-PAN-2 analysis as a tumor marker].
Sawabu N; Satomura Y
Nihon Rinsho; 1990 Feb; 48 Suppl():1003-7. PubMed ID: 2162408
[No Abstract] [Full Text] [Related]
15. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA].
Okamura Y; Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1279-85. PubMed ID: 2069399
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
[TBL] [Abstract][Full Text] [Related]
17. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
Nakahara M; Fujisawa K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of CA125 assay as a tumor marker].
Ariyoshi Y; Kuwabara M; Kuzuya K
Nihon Rinsho; 1990 Feb; 48 Suppl():978-81. PubMed ID: 2192183
[No Abstract] [Full Text] [Related]
19. [Study on the clinical usefulness of NCC-ST-439 in breast cancer].
Takahashi H; Nakanishi K; Taguchi K; Hasumi T; Hamada H; Sasaki F; Hata Y; Uchino J
Gan To Kagaku Ryoho; 1991 Feb; 18(2):245-9. PubMed ID: 1992918
[TBL] [Abstract][Full Text] [Related]
20. [Serodiagnosis: tumor marker].
Yoneshima M; Hattori N; Sawabu N
Gan No Rinsho; 1988 Aug; 34(10):1209-15. PubMed ID: 2459425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
